Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

The third most common form of dementia is often mistaken for Alzheimer's despite different treatment needsCognitive profiles ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

This specifically involved distinguishing between Alzheimer's disease, the most common form of dementia, and Lewy body ...

The way in which we walk might hold the key to diagnosing Alzheimer's, or other types of dementia. Ground-breaking research ...

Researchers believe a simple blood test could flag people who are in the early stages of Alzheimer's, as well as spotting ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for Alzheimer’s disease in 2025.

All 16 of Indiana’s designated senior care organizations are now required to have a dementia outreach specialist. The goal is ...

After 12 months' treatment ... place within four years in a new position paper. Eli Lilly has another approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the ...